University of Aberdeen Takes you to the main page for this section

latest releases | archive

Alzheimer’s lecture brings in the crowds

More than 300 people are expected to descend on the University of Aberdeen tomorrow night (September 16) for a talk by a scientist who announced in the summer news of an Alzheimer’s breakthrough.

Professor Claude WischikProfessor Claude Wischik made headlines across the world in July when he and his research team revealed the results of a trial of a new treatment for Alzheimer's disease.

The Professor of Psychiatric Geratology and Old Age Psychiatry at the University of Aberdeen described how a Phase 2 trial of the drug rember™ appears to slow the progress of the disorder by 81% over a year.

The new therapy was developed by Professor Wischik's research team, together with TauRx Therapeutics, which is a Singapore based company spun out of the University.

Professor Wischik, who is Chairman of TauRx Therapeutics, will outline details of the trial at tomorrow night's Alzheimer's Research Trust public lecture which is taking place at 6pm at the University's Arts Lecture Theatre.

Places are still available at the lecture which is free and open to all. To reserve a seat at the event contact Karen Scaife at the University of Aberdeen Events Office on 01224 273233 or email

PLEASE NOTE: The Phase 2 clinical trial has now ended. A Phase 3 clinical trial is planned for next year. Recruitment has not begun and it is not yet known where the trial will take place. rember™   is not available on the market.


For more information about the trial please see:



Notes to Editors

Issued by the Communications Team, Office of External Affairs, University of Aberdeen, King's College, Aberdeen. Tel: (01224) 272014.

Issued on: Monday 15th of September 2008

Contact: Jennifer Phillips

<< back

University Switchboard: +44 (0)1224 272000
Enquiries about studying at The University of Aberdeen should be directed to